Skip to main content

Table 5 Median progression-free survival (mPFS) and median overall survival (mOS) for different scores in patients stratified according to presence of different independent prognostic factors obtained from multivariate analysis (TC and LDL)

From: Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib

Prognosis

Score

95%CI

P value

0(n = 75)

1(n = 19)

2(n = 43)

mPFS (months)

5.8

4.8

1.5

3.142–4.858

0.000

mOS (months)

9.9

7.9

5.6

6.843–9.757

0.017

  1. The unit of measurement for lipids is mmol/L
  2. TC total cholesterol, LDL low density lipoprotein, CI confidence interval
  3. A score of 0 represents low TC (< 4.77) and low LDL (< 2.965) at baseline; a score of 1 denotes low TC (< 4.77) and high LDL (≥ 2.965) or low LDL (< 2.965) and high TC (≥ 4.77) at baseline; whereas 2 represents high TC (≥ 4.77) and high LDL (≥ 2.965) at baseline
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X